Free online reference management for clinicians and scientists

Sign up now

Recent "cml" articles

  • These articles and links have been posted by Connotea users using the tag "cml".
  • To add to this collection, or to start your own library:

Learn more

Watch a short video (2m 41s)

EXPORT LIST RSS ?
Bookmarks matching tag cml
 
Number of articles per page:
10 | 25 | 50 | 100
 
Tyrosine kinase inhibitors and allogeneic hematopoietic cell transplantation for chronic myeloid leukemia: targeting both therapeutic modalities.
Hugo F Fernandez and Mohamed A Kharfan-Dabaja
Cancer control : journal of the Moffitt Cancer Center 16 (2), 153-7 (Apr 2009)
Posted by nanog to CML JAK-2 on Wed Jun 24 2009 at 23:53 UTC | info | related
 
Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia
Yaoyu Chen et al.
Nat Genet, published online 07 Jun 2009
Posted by nanog to CML Leukemic SC bcr-abl on Mon Jun 08 2009 at 03:45 UTC | info | related
 
Towards Cure of CML: Why We Need to Know More About CML Stem Cells.
Jeroen J W M Janssen et al.
Current stem cell research & therapy, (01 Sep 2009)
Posted by nanog to Leukemic SC CML on Sat Jun 06 2009 at 20:15 UTC | info | related
 
The CML stem cell: Evolution of the progenitor
www.landesbioscience.com
Posted by nanog to reviews CML Leukemic SC on Sat May 09 2009 at 03:48 UTC | info | related
 
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.
Cristian Bellodi et al.
The Journal of clinical investigation, (13 Apr 2009)
Posted by nanog to bcr-abl CML Leukemic SC on Wed Apr 15 2009 at 01:55 UTC | info | related
 
The CML stem cell: Evolution of the progenitor.
Scott Stuart, Yosuke Minami, and Jean Wang
Cell cycle (Georgetown, Tex.) 8 (9), (17 May 2009)
Posted by nanog to leukemia CML on Sat Apr 04 2009 at 15:43 UTC | info | related
 
Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice
Y Chen et al.
Leukemia, (26 Mar 2009)
Posted by nanog to bcr-abl CML Leukemic SC on Tue Mar 31 2009 at 16:20 UTC | info | related
 
Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia.
Neil P Shah et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26 (19), 3204-12 (01 Jul 2008)
 
Cancer induction by restriction of oncogene expression to the stem cell compartment
María Pérez-Caro et al.
The EMBO journal 28 (1), 8-20 (27 Nov 2008)
Posted by leuk and 1 other to Stem Cells CML on Wed Jan 21 2009 at 15:43 UTC | info | related
 
Kinase inhibitors: Thinking outside the box
Sarah Seton-Rogers
Nat Rev Cancer, published online 29 Dec 2008
Posted by uzgiris to CML bcr-abl Apoptosis on Sat Jan 10 2009 at 00:23 UTC | info | related

<< Prev 0      Showing entries 1 to 10 of 72 total      Next 10 >>